Linc-ROR promotes esophageal squamous cell carcinoma progression through the derepression of SOX9

BACKGROUND: Novel therapies tailored to the molecular composition of esophageal squamous cell carcinoma (ESCC) are needed to improve patient survival. We investigated the regulatory network of long intergenic non-protein coding RNA, regulator of reprogramming (linc-ROR) and sex-determining region Y-...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Exp Clin Cancer Res
Auteurs principaux: Wang, Lianghai, Yu, Xiaodan, Zhang, Zhiyu, Pang, Lijuan, Xu, Jiang, Jiang, Jinfang, Liang, Weihua, Chai, Yuhang, Hou, Jun, Li, Feng
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2017
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5727696/
https://ncbi.nlm.nih.gov/pubmed/29237490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-017-0658-2
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires